Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kobrin

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Circulation|November 14, 1997
Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trialD Tzivoni, H Kadr, S Braat, et al.
The American Journal of Cardiology|March 1, 1985
Immediate hemodynamic effects of urapidil in patients with essential hypertensionI Kobrin, C Amodeo, H O Ventura, et al.
The American Journal of Medicine|October 5, 1984
Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive ratsB L Pegram, I Kobrin, T Natsume, et al.
The American Journal of Physiology|July 1, 1984
Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in ratI Kobrin, M B Kardon, W Oigman, et al.
Journal of Hypertension|April 1, 1985
Renal response to acute volume overload in conscious rats with atrial appendectomyI Kobrin, M B Kardon, N C Trippodo, et al.
The American Journal of Cardiology|April 1, 1985
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertensionH O Ventura, E D Frohlich, F H Messerli, et al.
Circulation|August 1, 1987
Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenololF G Dunn, H O Ventura, F H Messerli, et al.
American Heart Journal|August 1, 1997
Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokineticsM Bursztyn, H Kadr, R Tilvis, et al.
British Journal of Clinical Pharmacology|December 1, 1993
Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patientsC Weber, H Birnböck, J Leube, et al.
The American Journal of Medicine|May 31, 1984
Immediate regional blood flow distribution following angiotensin converting enzyme inhibition in patients with essential hypertensionH O Ventura, E D Frohlich, F H Messerli, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Circulation|November 14, 1997
Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trialD Tzivoni, H Kadr, S Braat, et al.
The American Journal of Cardiology|March 1, 1985
Immediate hemodynamic effects of urapidil in patients with essential hypertensionI Kobrin, C Amodeo, H O Ventura, et al.
The American Journal of Medicine|October 5, 1984
Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive ratsB L Pegram, I Kobrin, T Natsume, et al.
The American Journal of Physiology|July 1, 1984
Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in ratI Kobrin, M B Kardon, W Oigman, et al.
Journal of Hypertension|April 1, 1985
Renal response to acute volume overload in conscious rats with atrial appendectomyI Kobrin, M B Kardon, N C Trippodo, et al.
The American Journal of Cardiology|April 1, 1985
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertensionH O Ventura, E D Frohlich, F H Messerli, et al.
Circulation|August 1, 1987
Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenololF G Dunn, H O Ventura, F H Messerli, et al.
American Heart Journal|August 1, 1997
Mibefradil, a novel calcium antagonist, in elderly patients with hypertension: favorable hemodynamics and pharmacokineticsM Bursztyn, H Kadr, R Tilvis, et al.
British Journal of Clinical Pharmacology|December 1, 1993
Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patientsC Weber, H Birnböck, J Leube, et al.
The American Journal of Medicine|May 31, 1984
Immediate regional blood flow distribution following angiotensin converting enzyme inhibition in patients with essential hypertensionH O Ventura, E D Frohlich, F H Messerli, et al.
Pageof 13